Journals / art / 2015 / Cilt: 30 - Sayı: 1

Bath ankilozan spondilit hastalık aktivite indeksi eşlik eden fibromyalji ya da depresyondan etkilenebilir mi?

Can bath ankylosing spondylitis disease activity ındex be affected by accompanying fibromyalgia or depression?

Journal
art
Pages
34–39
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings suggest that while assessing disease activity in patients with AS particularly by a patient-reported outcome measure such as BASDAI, other conditions such as FM and depression which may affect the scores should be taken into consideration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate whether Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is affected from pathologies such as fibromyalgia (FM) and depression which may coexist in patients with ankylosing spondylitis (AS).
📊
Key Findings & Data:Patients and methods: A total of 170 patients (57 males, 123 females; mean age 42.9±13.0 years) aged between 18 and 75 years with FM (n=52), depression (n=60) and AS (n=58) were included in the study.
💡
Conclusion & Impact:Conclusion: Our findings suggest that while assessing disease activity in patients with AS particularly by a patient-reported outcome measure such as BASDAI, other conditions such as FM and depression which may affect the scores should be taken into consideration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to investigate whether Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is affected from pathologies such as fibromyalgia (FM) and depression which may coexist in patients with ankylosing spondylitis (AS). Patients and methods: A total of 170 patients (57 males, 123 females; mean age 42.9±13.0 years) aged between 18 and 75 years with FM (n=52), depression (n=60) and AS (n=58) were included in the study. All patients were asked to complete BASDAI and Beck Depression Inventory. Percentages of patients with BASDAI scores of >4 (cut-off value for disease activity) and >5 (cut-off value for reimbursement of biological agents) were calculated and compared between the groups. Individual BASDAI item scores, total BASDAI, and Beck Depression Inventory scores were compared between the groups. Results: When individual BASDAI items scores were analyzed separately, scores of all items were statistically significantly higher in FM group compared to AS group. While question 1 (fatigue) and 3 (peripheral joint pain and swelling) scores were statistically significantly higher in the depression group compared to AS group, question 5 and 6 scores (items associated with morning stiffness) were significantly lower in the depression group compared to AS group. Percentage of patients with BASDAI scores of >4 and >5 in the FM group was significantly higher compared to the other two groups. Significant correlation was noted between BASDAI and Beck Depression Inventory scores in AS and FM groups. Conclusion: Our findings suggest that while assessing disease activity in patients with AS particularly by a patient-reported outcome measure such as BASDAI, other conditions such as FM and depression which may affect the scores should be taken into consideration.

Özet

Amaç: Bu çalışmada Bath Ankilozan Spondilit Hastalık Aktivite İndeksinin (BASDAI) ankilozan spondilitli (AS) hastalarda birlikte var olabilen fibromiyalji (FM) ve depresyon gibi patolojilerden etkilenip etkilenmediği araştırıldı. Hastalar ve yöntemler: Yaşları 18 ile 75 arasında değişen FM’li (n=52), depresyonlu (n=60) ve AS’li (n=58) toplam 170 hasta (57 erkek, 123 kadın; ort. yaş 42.9±13.0 yıl) çalışmaya dahil edildi. Tüm hastalardan BASDAI’yi ve Beck Depresyon Ölçeğini doldurmaları istendi. BASDAI skorları >4 (hastalık aktivitesi için kestirim değeri) ve >5 (biyolojik ajan geri ödemesi için kestirim değeri) olan hastaların yüzdeleri hesaplanarak gruplar arasında karşılaştırıldı. Bireysel BASDAI alt skorları, toplam BASDAI ve Beck Depresyon Ölçeği skorları gruplar arasında karşılaştırıldı. Bulgular: Bireysel BASDAI maddelerinin skorları ayrı ayrı analiz edildiğinde, tüm maddelerin skorları FM grubunda AS grubuna kıyasla istatistiksel olarak anlamlı şekilde yüksekti. Soru 1 (yorgunluk) ve 3 (periferik eklem ağrısı ve şişlik) skorları AS grubuna kıyasla depresyon grubunda istatistiksel olarak anlamlı şekilde yüksek iken, soru 5 ve 6 skorları (sabah tutukluğu ile ilişkili olan maddeler) AS grubuna kıyasla depresyon grubunda anlamlı şekilde düşüktü. BASDAI skorları >4 ve >5 olan hastaların yüzdesi FM grubunda diğer iki gruba kıyasla anlamlı şekilde yüksekti. AS ve FM gruplarında BASDAI ve Beck Depresyon Ölçeği skorları arasında anlamlı ilişki vardı. Sonuç: Çalışmamızın sonuçları AS’de hastalık aktivitesi özellikle BASDAI gibi hasta bildirimli bir öz değerlendirme ölçeğiyle değerlendirilirken skorları etkileyebilecek FM ve depresyon gibi diğer durumların da göz önünde bulundurulması gerektiğini düşündürmektedir.

🔖

Cite This Article

İNCEOĞLU, L. A., SİVRİOĞLU, Y., ERCAN, İ. (2015). Bath ankilozan spondilit hastalık aktivite indeksi eşlik eden fibromyalji ya da depresyondan etkilenebilir mi?. art, Cilt: 30 - Sayı: 1, 34–39. https://ajindex.com/articles/197498

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Khan MA. Ankylosing spondylitis: introductory comments on its diagnosis and treatment. Ann Rheum Dis 2002
  2. 3–7. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994
  3. 2286–91. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005
  4. 280–4. Bradley LA, Alarcon GS. Fibromyalgia. In: Kopman WJ, editor. Arthritis and allied conditions. Philadelphia: Lippincott Williams & Wilkins
  5. p. 1811–44. Linton SJ, Sofia Bergbom S. Understanding the link between depression and pain. Scan J Pain 2011
  6. 47–54. Demyttenaere K, Reed C, Quail D, Bauer M, Dantchev N, Montejo AL, et al. Presence and predictors of pain in depression: results from the FINDER study. J Affect Disord 2010
  7. 53–60. Gambassi G. Pain and Depression Chicken and Egg Problem Revisited. Arch Gerontol Geriatr 2009
  8. Suppl 1:103–12. de Vlam K. Soluble and tissue biomarkers in ankylosing spondylitis. Best Pract Res Clin Rheumatol 2010
  9. 671–82. Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken) 2011
  10. 63 Suppl 11:S47-58. Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009
  11. Heikkilä S, Ronni S, Kautiainen HJ, Kauppi MJ. Functional impairment in spondyloarthropathy and fibromyalgia. J Rheumatol 2002
  12. 1415–9. Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993
  13. 1925–31. Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012
  14. 584573. Buskila D, Odes LR, Neumann L, Odes HS. Fibromyalgia in inflammatory bowel disease. J Rheumatol 1999
  15. 1167–71. Almodóvar R, Carmona L, Zarco P, Collantes E, González C, Mulero J